Garnet Vanterpool
Garnet Vanterpool publishes mostly in Surgery, Hepatology and Pulmonary and Respiratory Medicine, on topics such as Hepatocellular Carcinoma Treatment and Prognosis, Gallbladder and Bile Duct Disorders and Pancreatic and Hepatic Oncology Research.
- World rank
- #2,521,590 of 7,710,434 ranked researchers
- Rank in United States
- #742,716 of 1,627,098
- Works
- 16
- Citations
- 17
- Citations per work
- 1.1
What does Garnet Vanterpool research?
Garnet Vanterpool's work is mostly in Medicine (83%), Engineering (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1382.9%
- Medicine1382.9%
- Everything else212.2%
- Physical Sciences14.9%
- Engineering14.9%
- 1Surgery39% of their works
- 2Hepatology17% of their works
- 3Pulmonary and Respiratory Medicine15% of their works
- 4Oncology7% of their works
- 5Biomedical Engineering5% of their works
- 6Gastroenterology5% of their works
Research topics
- Hepatocellular Carcinoma Treatment and Prognosis
- Gallbladder and Bile Duct Disorders
- Pancreatic and Hepatic Oncology Research
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Gastrointestinal Tumor Research and Treatment
- Gastric Cancer Management and Outcomes
- Pancreatitis Pathology and Treatment
- Organ Transplantation Techniques and Outcomes
Which keywords describe Garnet Vanterpool's research?
The keywords of their largest research topics: Clinical Practice Guidelines, Cholangiocarcinoma, Hepatocellular Carcinoma, Liver Cancer, Chemotherapy, Epidemiology, Surgical Management and Cholecystitis.
- Liver Transplantation
- Imatinib Mesylate
- Endoscopic Resection
- Acute Pancreatitis
- Pancreatic Cancer
- Biliary Tract Cancer
- Cholecystitis
- Epidemiology
- Liver Cancer
- Cholangiocarcinoma
- Clinical Practice Guidelines
- Hepatocellular Carcinoma
- Chemotherapy
- Surgical Management
- ERCP
- Intrahepatic Cholangiocarcinoma
- Surgical Complications
- Chronic Pancreatitis
- Gastric Cancer
- Ischemia-Reperfusion Injury
- Sunitinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Clinical Practice Guidelines92 topics
- Cholangiocarcinoma72 topics
- Hepatocellular Carcinoma71 topic
- Liver Cancer71 topic
- Chemotherapy52 topics
- Epidemiology52 topics
- Surgical Management52 topics
- Cholecystitis41 topic
- ERCP41 topic
- Biliary Tract Cancer31 topic
- Intrahepatic Cholangiocarcinoma31 topic
- Pancreatic Cancer31 topic
- Surgical Complications31 topic
- Acute Pancreatitis21 topic
- Chronic Pancreatitis21 topic
- Endoscopic Resection21 topic
- Gastric Cancer21 topic
- Imatinib Mesylate21 topic
- Ischemia-Reperfusion Injury21 topic
- Liver Transplantation21 topic
- Sunitinib21 topic
Where does Garnet Vanterpool work?
Garnet Vanterpool's main affiliation in the publication record is AdventHealth Tampa, United States.
How many publications and citations does Garnet Vanterpool have?
OpenAlex counts 16 works and 17 citations for Garnet Vanterpool, an h-index of 2, ranking #2,521,590 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Garnet Vanterpool. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.